Schrodinger, Inc. (SDGR)

↓ Download CSV

CIK 0001490978 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Schrodinger, Inc. reported revenue of $255.87M, up 23.3% from the prior year. The company ran a net loss, with a net margin of -40.4% and a gross margin of 55.7%. It held $726.16M in total assets against $362.11M in total liabilities.

Key ratios (FY2025)

55.7%
Gross margin
-65.2%
Operating margin
-40.4%
Net margin
-28.4%
Return on equity
+23.3%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019
Revenue$255.87M$207.54M$216.67M$180.96M$137.93M$108.09M$85.54M
Cost of Revenue$113.25M$75.46M$75.97M$79.93M$72.31M$44.62M$36.45M
Gross Profit$142.61M$132.08M$140.69M$101.02M$65.62M$63.47M$49.09M
Operating Income-$166.90M-$209.30M-$177.45M-$146.82M-$111.44M-$60.92M-$38.72M
Net Income-$103.27M-$187.12M$40.72M-$149.19M-$100.39M-$24.46M-$24.57M
EPS (Diluted)$-1.41$-2.57$0.54$-2.10$-1.42$-0.41
Total Assets$726.16M$823.23M$802.96M$688.59M$756.49M$746.26M$155.27M
Total Liabilities$362.11M$401.78M$254.40M$240.68M$199.40M$122.24M$57.01M
Shareholders' Equity$364.05M$421.44M$548.56M$447.89M$557.07M$624.01M-$93.36M
Cash & Equivalents$230.52M$147.33M$155.31M$90.47M$120.27M$202.30M$25.99M
Operating Cash Flow$13.90M-$157.37M-$136.73M-$119.68M-$70.67M$16.76M-$26.06M
Capital Expenditures$1.44M$7.31M$13.40M$8.01M$7.17M$2.54M$1.84M
Shares Outstanding73.44M72.67M74.99M71.17M70.59M60.02M